CLVRX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CLVRX Analyst Rating

Moderate Buy

428 Buy

104 Hold

9 Sell

Based on the consensus analyst ratings on 541 stocks held in CLVRX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CLVRX Analyst Price Target

Average Price Target

$35.64

Based on 541 Wall Street analysts offering 12 month price targets to Calvert US Large-Cap Value Responsible Index Fund - Class R6 holdings in the last 3 months. The average price target is $35.64 with a high forecast of $43.04 and a low forecast of $30.19. The average price target represents a 11.27% change from the last price of $32.03.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"27":"$27","44":"$44","31.25":"$31.3","35.5":"$35.5","39.75":"$39.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":43.04,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$43.04</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.641,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$35.64</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.186,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$30.19</span>\n  </div></div>","useHTML":true}}],"tickPositions":[27,31.25,35.5,39.75,44],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.52,32.40615384615385,33.292307692307695,34.17846153846154,35.06461538461539,35.95076923076923,36.83692307692308,37.723076923076924,38.60923076923077,39.495384615384616,40.38153846153846,41.26769230769231,42.15384615384615,{"y":43.04,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.52,31.837,32.153999999999996,32.471,32.788,33.105,33.422,33.739,34.056,34.373,34.69,35.007,35.324,{"y":35.641,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.52,31.417384615384616,31.31476923076923,31.212153846153846,31.10953846153846,31.006923076923076,30.904307692307693,30.801692307692306,30.699076923076923,30.59646153846154,30.493846153846153,30.39123076923077,30.288615384615383,{"y":30.186,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":28.77,"date":1714521600000,"info":"<div>Price: <b>$29<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.53,"date":1717372800000,"info":"<div>Price: <b>$30<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.18,"date":1719792000000,"info":"<div>Price: <b>$29<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":30.68,"date":1722470400000,"info":"<div>Price: <b>$31<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":31.46,"date":1725321600000,"info":"<div>Price: <b>$31<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":32.18,"date":1727740800000,"info":"<div>Price: <b>$32<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":32.12,"date":1730419200000,"info":"<div>Price: <b>$32<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":34.22,"date":1733097600000,"info":"<div>Price: <b>$34<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":31.93,"date":1735776000000,"info":"<div>Price: <b>$32<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.47,"date":1738540800000,"info":"<div>Price: <b>$33<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.44,"date":1740960000000,"info":"<div>Price: <b>$33<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":32.36,"date":1743465600000,"info":"<div>Price: <b>$32<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":31.52,"date":1746057600000,"info":"<div>Price: <b>$32<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$43.04

Average Price Target$35.64

Lowest Price Target$30.19

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

CLVRX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PCVX

Vaxcyte, Inc.

11 Buy

0 Hold

0 Sell

Strong Buy

$117.88

xxxxxxxxxxxxxxxxxxxxxxxxxxx

VKTX

Viking Therapeutics

15 Buy

1 Hold

0 Sell

Strong Buy

$92.07

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CYTK

Cytokinetics

17 Buy

2 Hold

0 Sell

Strong Buy

$76.87

xxxxxxxxxxxxxxxxxxxxxxxxxxx

APLS

Apellis Pharmaceuticals

14 Buy

8 Hold

0 Sell

Moderate Buy

$37.55

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RVMD

Revolution Medicines, Inc.

10 Buy

0 Hold

0 Sell

Strong Buy

$70.11

CLVRX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GME

GameStop Corp

0 Buy

0 Hold

1 Sell

Moderate Sell

$13.50

xxxxxxxxxxxxxxxxxxxxxxxxxxx

LFUS

Littelfuse

1 Buy

2 Hold

0 Sell

Moderate Buy

$148.00

xxxxxxxxxxxxxxxxxxxxxxxxxxx

FIVE

Five Below Inc

6 Buy

13 Hold

1 Sell

Hold

$96.12

xxxxxxxxxxxxxxxxxxxxxxxxxxx

WTS

Watts Water

1 Buy

3 Hold

0 Sell

Hold

$204.50

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RBLX

Roblox Corp.

14 Buy

5 Hold

2 Sell

Moderate Buy

$74.19

CLVRX Mutual Fund FAQ

What is CLVRX’s average 12-month price target, according to analysts?

Based on analyst ratings, Calvert US Large-Cap Value Responsible Index Fund - Class R6’s 12-month average price target is 35.64.

What is CLVRX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CLVRX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CLVRX a Buy, Sell or Hold?

Calvert US Large-Cap Value Responsible Index Fund - Class R6 has a consensus rating of Moderate Buy which is based on 428 buy ratings, 104 hold ratings and 9 sell ratings.

What is Calvert US Large-Cap Value Responsible Index Fund - Class R6’s price target?

The average price target for Calvert US Large-Cap Value Responsible Index Fund - Class R6 is 35.64. This is based on 541 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $43.04 ,the lowest forecast is $30.19. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about Calvert US Large-Cap Value Responsible Index Fund - Class R6?

Calvert US Large-Cap Value Responsible Index Fund - Class R6’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 541 Wall Streets Analysts.

How can I buy shares of CLVRX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing